Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021
IntroductionThe burden of chronic kidney disease (CKD) varies across regions. This study provides comprehensive global, regional, and national estimates of total CKD and CKD due to four specific etiologies from 1990 to 2021.MethodsData were extracted from the 2021 Global Burden of Disease study, cat...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2025-07-01
|
| Series: | Frontiers in Public Health |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1542329/full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849243723569823744 |
|---|---|
| author | Lanhui Wang Yining He Chao Han Chao Han Peiqi Zhu Yaping Zhou Ruijie Tang Weiming He |
| author_facet | Lanhui Wang Yining He Chao Han Chao Han Peiqi Zhu Yaping Zhou Ruijie Tang Weiming He |
| author_sort | Lanhui Wang |
| collection | DOAJ |
| description | IntroductionThe burden of chronic kidney disease (CKD) varies across regions. This study provides comprehensive global, regional, and national estimates of total CKD and CKD due to four specific etiologies from 1990 to 2021.MethodsData were extracted from the 2021 Global Burden of Disease study, categorized by sex, 20 age groups, 204 countries or territories, and 5 sociodemographic index (SDI) regions. Age-standardized incidence rates (ASIRs), age-standardized prevalence rates (ASPRs), age-standardized death rates (ASDRs), age-standardized disability-adjusted life year rates (ASDARs) and risk factor burdens for total CKD and four etiology-specific types were analyzed. Temporal trends were assessed using the estimated annual percentage change.ResultsIn 2021, CKD remained a significant global burden, with 673 million prevalent cases and 1.5 million deaths, primarily due to metabolic risk factors. The fastest growth in the ASPR and ASIR occurred in the middle-SDI regions, whereas the highest ASDR and ASDAR were observed in low-SDI regions. From 1990 to 2021, global ASIR increased for CKD caused by all four specific etiologies. The ASDR and ASDAR increased for CKD due to type 2 diabetes, glomerulonephritis, and hypertension, whereas there was a decline in CKD due to type 1 diabetes.DiscussionBetween 1990 and 2021, CKD-related disability-adjusted life years (DALYs) and deaths increased substantially, with type 2 diabetes and hypertension accounting for half of the etiology-specific DALYs in 2021. Effective health policies are urgently needed to address CKD risk factors and implement prevention strategies. |
| format | Article |
| id | doaj-art-13e61ab62e7a4e57a1e7989a4a1d05d8 |
| institution | Kabale University |
| issn | 2296-2565 |
| language | English |
| publishDate | 2025-07-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Public Health |
| spelling | doaj-art-13e61ab62e7a4e57a1e7989a4a1d05d82025-08-20T03:59:22ZengFrontiers Media S.A.Frontiers in Public Health2296-25652025-07-011310.3389/fpubh.2025.15423291542329Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021Lanhui Wang0Yining He1Chao Han2Chao Han3Peiqi Zhu4Yaping Zhou5Ruijie Tang6Weiming He7Division of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDivision of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDivision of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaYancheng Dafeng Hospital of Chinese Medicine, Teaching Hospital of Nanjing University of Chinese Medicine, Yancheng, ChinaDivision of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDivision of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDivision of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaDivision of Nephrology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, ChinaIntroductionThe burden of chronic kidney disease (CKD) varies across regions. This study provides comprehensive global, regional, and national estimates of total CKD and CKD due to four specific etiologies from 1990 to 2021.MethodsData were extracted from the 2021 Global Burden of Disease study, categorized by sex, 20 age groups, 204 countries or territories, and 5 sociodemographic index (SDI) regions. Age-standardized incidence rates (ASIRs), age-standardized prevalence rates (ASPRs), age-standardized death rates (ASDRs), age-standardized disability-adjusted life year rates (ASDARs) and risk factor burdens for total CKD and four etiology-specific types were analyzed. Temporal trends were assessed using the estimated annual percentage change.ResultsIn 2021, CKD remained a significant global burden, with 673 million prevalent cases and 1.5 million deaths, primarily due to metabolic risk factors. The fastest growth in the ASPR and ASIR occurred in the middle-SDI regions, whereas the highest ASDR and ASDAR were observed in low-SDI regions. From 1990 to 2021, global ASIR increased for CKD caused by all four specific etiologies. The ASDR and ASDAR increased for CKD due to type 2 diabetes, glomerulonephritis, and hypertension, whereas there was a decline in CKD due to type 1 diabetes.DiscussionBetween 1990 and 2021, CKD-related disability-adjusted life years (DALYs) and deaths increased substantially, with type 2 diabetes and hypertension accounting for half of the etiology-specific DALYs in 2021. Effective health policies are urgently needed to address CKD risk factors and implement prevention strategies.https://www.frontiersin.org/articles/10.3389/fpubh.2025.1542329/fullchronic kidney diseasediabetes mellitusepidemiologyglobal burden of disease studyglomerulonephritishypertension |
| spellingShingle | Lanhui Wang Yining He Chao Han Chao Han Peiqi Zhu Yaping Zhou Ruijie Tang Weiming He Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021 Frontiers in Public Health chronic kidney disease diabetes mellitus epidemiology global burden of disease study glomerulonephritis hypertension |
| title | Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021 |
| title_full | Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021 |
| title_fullStr | Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021 |
| title_full_unstemmed | Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021 |
| title_short | Global burden of chronic kidney disease and risk factors, 1990–2021: an update from the global burden of disease study 2021 |
| title_sort | global burden of chronic kidney disease and risk factors 1990 2021 an update from the global burden of disease study 2021 |
| topic | chronic kidney disease diabetes mellitus epidemiology global burden of disease study glomerulonephritis hypertension |
| url | https://www.frontiersin.org/articles/10.3389/fpubh.2025.1542329/full |
| work_keys_str_mv | AT lanhuiwang globalburdenofchronickidneydiseaseandriskfactors19902021anupdatefromtheglobalburdenofdiseasestudy2021 AT yininghe globalburdenofchronickidneydiseaseandriskfactors19902021anupdatefromtheglobalburdenofdiseasestudy2021 AT chaohan globalburdenofchronickidneydiseaseandriskfactors19902021anupdatefromtheglobalburdenofdiseasestudy2021 AT chaohan globalburdenofchronickidneydiseaseandriskfactors19902021anupdatefromtheglobalburdenofdiseasestudy2021 AT peiqizhu globalburdenofchronickidneydiseaseandriskfactors19902021anupdatefromtheglobalburdenofdiseasestudy2021 AT yapingzhou globalburdenofchronickidneydiseaseandriskfactors19902021anupdatefromtheglobalburdenofdiseasestudy2021 AT ruijietang globalburdenofchronickidneydiseaseandriskfactors19902021anupdatefromtheglobalburdenofdiseasestudy2021 AT weiminghe globalburdenofchronickidneydiseaseandriskfactors19902021anupdatefromtheglobalburdenofdiseasestudy2021 |